88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis SHANGHAI , June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly ... 2026-06-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 12, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the ... 2026-06-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. ... 2026-06-11T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Cynosure Lutronic's XERF™, Worldwide Adoption Accelerates, Now 3x Faster Now among the fastest-scaling monopolar RF devices worldwide, XERF™ has more than tripled its pace of adoption in recent months with Asia-Pacific and North America leading the surge. ... 2026-06-11T Biotechnology Cosmetics & Personal Care Fashion Health Care/Hospital
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights SUZHOU, China , June 11, 2026 /PRNewswire/ -- The clinical datasets presented at ASCO 2026 by CStone further validate the trispecific synergistic mechanism of CS2009 and support its potential ... 2026-06-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health Backed by International Authority — Caliway's latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weight–loss therapies, were presented ... 2026-06-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ... 2026-06-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. Enables comprehensive field evaluation of a diversified ... 2026-06-11T Agriculture Biotechnology Health Care/Hospital
HkeyBio Launches "NHP Fast-PoC" Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices The cost-effective platform delivers rapid pharmacological validation data in cynomolgus monkeys, helping biotech firms make confident R&D decisions before committing to full-scale IND studies. ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NOROO Holdings Advances Commercialization of Bio-Based 3-HP Through Major Korean Government Initiative Selected as the lead organization for a major government-backed initiative to accelerate commercialization of bio-based 3-HP through pilot-scale investments. Establishing an integrated R&D value ... 2026-06-10T Alternative Energies Biotechnology Chemical Environmental Products & Services

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved